2-85663170-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000542.5(SFTPB):c.1002+176A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.459 in 152,084 control chromosomes in the GnomAD database, including 18,682 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.46 ( 18682 hom., cov: 33)
Consequence
SFTPB
NM_000542.5 intron
NM_000542.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.20
Publications
18 publications found
Genes affected
SFTPB (HGNC:10801): (surfactant protein B) This gene encodes the pulmonary-associated surfactant protein B (SPB), an amphipathic surfactant protein essential for lung function and homeostasis after birth. Pulmonary surfactant is a surface-active lipoprotein complex composed of 90% lipids and 10% proteins which include plasma proteins and apolipoproteins SPA, SPB, SPC and SPD. The surfactant is secreted by the alveolar cells of the lung and maintains the stability of pulmonary tissue by reducing the surface tension of fluids that coat the lung. The SPB enhances the rate of spreading and increases the stability of surfactant monolayers in vitro. Multiple mutations in this gene have been identified, which cause pulmonary surfactant metabolism dysfunction type 1, also called pulmonary alveolar proteinosis due to surfactant protein B deficiency, and are associated with fatal respiratory distress in the neonatal period. Alternatively spliced transcript variants encoding the same protein have been identified.[provided by RefSeq, Feb 2010]
SFTPB Gene-Disease associations (from GenCC):
- surfactant metabolism dysfunction, pulmonary, 1Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 2-85663170-T-C is Benign according to our data. Variant chr2-85663170-T-C is described in ClinVar as Benign. ClinVar VariationId is 1272295.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.742 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SFTPB | NM_000542.5 | c.1002+176A>G | intron_variant | Intron 8 of 10 | ENST00000519937.7 | NP_000533.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SFTPB | ENST00000519937.7 | c.1002+176A>G | intron_variant | Intron 8 of 10 | 1 | NM_000542.5 | ENSP00000428719.2 |
Frequencies
GnomAD3 genomes AF: 0.459 AC: 69686AN: 151966Hom.: 18628 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
69686
AN:
151966
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.459 AC: 69802AN: 152084Hom.: 18682 Cov.: 33 AF XY: 0.453 AC XY: 33665AN XY: 74348 show subpopulations
GnomAD4 genome
AF:
AC:
69802
AN:
152084
Hom.:
Cov.:
33
AF XY:
AC XY:
33665
AN XY:
74348
show subpopulations
African (AFR)
AF:
AC:
31100
AN:
41500
American (AMR)
AF:
AC:
6300
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
1029
AN:
3466
East Asian (EAS)
AF:
AC:
1755
AN:
5172
South Asian (SAS)
AF:
AC:
1538
AN:
4828
European-Finnish (FIN)
AF:
AC:
2931
AN:
10582
Middle Eastern (MID)
AF:
AC:
122
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23857
AN:
67948
Other (OTH)
AF:
AC:
923
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1705
3409
5114
6818
8523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
604
1208
1812
2416
3020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1330
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Dec 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.